Skip to content

    HIV & AIDS Health Center

    Font Size
    A
    A
    A

    78% of U.S. HIV Infections Drug Resistant

    By
    WebMD Health News
    Reviewed by Gary D. Vogin, MD

    Dec. 18, 2001 -- At least one AIDS drug no longer works for the vast majority of Americans living with HIV.

    Used in combination, the drugs are a lifeline. Now a nationwide study shows that many people may be reaching the end of that line.

    "It does mean patients are running out of options," study co-leader Samuel A. Bozzette, MD, PhD, tells WebMD. "And more are going to be out of options soon."

    Reported at the American Society for Microbiology's annual infectious disease conference, the findings paint a grim picture. They show that 78% of Americans being treated for HIV infection carry a virus that already is resistant to one or more anti-HIV drugs.

    "Treatment of HIV is going to be increasingly complicated," says Bozzette, a researcher at the University of California, San Diego, and the VA San Diego Healthcare System.

    That's bad news for doctors, already faced with an extremely complex situation. There now are 16 different FDA-approved drugs that fight the AIDS virus. They fall into three basic classes: nucleoside- and non-nucleoside-based reverse transcriptase inhibitors (NRTIs and NNRTIs) and protease inhibitors (PIs). A virus resistant to one drug often -- but not always -- is resistant to some or all of the other drugs in its class.

    The drugs must be used in combinations. People who begin treatment must continue for the rest of their lives. Some combinations work for some people, and some don't. There is no easy way to tell which drugs to start with -- or which drugs to switch to if the first combination fails.

    Studies suggest that one in five newly detected U.S. HIV infections already is resistant to at least one anti-HIV drug. Doctors have usually used resistance tests to see whether the drugs a patient is taking still work. Now doctors will have to use the relatively expensive tests in patients with new infections, Bozzette says.

    The study, begun in 1996, collects blood samples from more than 1,600 U.S. men and women with HIV infection. Samples tested in 1999 showed that:

    • 70% of samples were resistant to one or more NRTIs, the oldest class of anti-HIV drug.
    • 42% of samples were resistant to one or more PIs.
    • 31% of samples were resistant to one or more NNRTIs.
    • Resistance was much more common among people whose treatment was failing (based on HIV disease stage and measures of immune function).
    • Resistance was more common in people with the best access to treatment: non-Hispanic white males, highly educated people, people with private insurance, and men who have sex with men.

    Today on WebMD

    misconception
    How much do you know?
    contemplative man
    What to do now.
     
    research
    Should you be tested?
    HIV under microscope
    What does it mean?
     
    HIV AIDS Screening
    Slideshow
    man opening condom wrapper
    Quiz
     
    HIV AIDS Treatment
    Feature
    Discrimination Stigma
    Feature
     
    Treatment Side Effects
    Feature
    grilled chicken and vegetables
    Article
     
    obese man standing on scale
    Article
    cold sore
    Article